Evidence map›Paper›PMID 26282081›Full record

ArticleNature reviews. Rheumatology2015

Autoinflammation. Management of hereditary recurrent fevers--SHARE experience.

Guillaume Sarrabay, Isabelle Touitou

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature reviews. Rheumatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Guillaume SarrabayLaboratoire de Génétique des Maladies Rares et Autoinflammatoires, Hôpital Arnaud de Villeneuve, 34295 Montpellier Cedex 5, France.
Isabelle TouitouLaboratoire de Génétique des Maladies Rares et Autoinflammatoires, Hôpital Arnaud de Villeneuve, 34295 Montpellier Cedex 5, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although new therapeutic options are available for patients with autoinflammatory diseases, evidence-based treatment guidelines are lacking. An initiative in European paediatric rheumatology aims to develop best-practice recommendations for the management of these rare disorders.

Indexed as

Practice Guidelines as TopicCryopyrin-Associated Periodic SyndromesHereditary Autoinflammatory DiseasesHumansMevalonate Kinase Deficiency

Identifiers

PMID26282081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.